A meta-analysis of dizziness as an adverse reaction in novel endocrine therapy for advanced prostate cancer.

BMC Cancer · 2026 · PMC13289503 · PMID 42062949

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In contrast, Abi alone showed a trend towards increased risk (RR = 1.39, 95% CI: 1.00–1.93), while Dar alone demonstrated no significant association with dizziness risk (RR = 1.14, 95% CI: 0.69–1.88).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.